MCL-1 but not BCL-XL is critical for the development and sustained expansion of thymic lymphoma in p53-deficient mice

Grants

Funding Acknowledgements

This work was supported by grants and fellowships from the Cancer Council of Victoria (postdoctoral fellowship to S.G., Sydney Parker Smith postdoctoral research fellowship to A.R.D.D., and postgraduate research scholarship to L.J.V.), the Lady Tata Memorial Trust (postdoctoral research award to S.G.), National Health and Medical Research Council (program grant 1016701; National Health and Medical Research Council fellowship 1020363 (to A.S.), the Leukemia and Lymphoma Society (Specialized Centres of Research grant 7001-03, to A.S.), University of Melbourne International Research Scholarship (to S.G.), University of Melbourne International Fee Remission scholarship (to S.G.), Australian Postgraduate award (to A.R.D.D.), Cancer Therapeutics CRC Top-up scholarship (to S.G. and A.R.D.D.), and the operational infrastructure grants through the Australian Government Independent Research Institutes Infrastructure Support Scheme and the Victorian State Government Operational Infrastructure Support.